RPS6KB1 and breast carcinoma: Because p-S6K1 relays many signals to promote further oncogenic translations in tumourigenesis14, upregulation of p-S6K1 in the tumour has been suggested to be predictive of resistance to systemic therapies such as endocrine therapy and chemotherapy in breast cancer patients15–17.